Results 31 to 40 of about 21,448 (228)
Vaccines for cancer interception in familial adenomatous polyposis [PDF]
Mary L Disis, Disis Mary L
exaly +2 more sources
“De novo” familial adenomatous polyposis (FAP) presenting as rectal cancer
Familial adenomatous polyposis is an autosomal dominant disorder with familial predisposition. 25%‐30% cases arise "de novo," without any clinical or genetic evidence.
Riya Agrawal, Utpal De
doaj +1 more source
Introduction Ileal adenomas associated with familial adenomatous polyposis are a common finding. Many recent studies following panproctocolectomy for familial adenomatous polyposis have confirmed the presence of multiple ileal adenomas and an increase in
Hammad Ahmed +3 more
doaj +1 more source
The adenomatous polyposis coli protein unambiguously localizes to microtubule plus-ends and is involved in establishing parallel arrays of microtubule bundles in highly polarised epithelial cells [PDF]
Loss of full-length adenomatous polyposis coli (APC) protein correlates with the development of colon cancers in familial and sporadic cases. In addition to its role in regulating ß-catenin levels in the Wnt signaling pathway, the APC protein is ...
John B. Mackie +16 more
core +1 more source
Desmoids in familial adenomatous polyposis
Abstract Clinical desmoid disease affects approximately 10 per cent of patients with familial adenomatous polyposis (FAP); the subclinical rate is unknown. Desmoids are probably neoplastic rather than regenerative in origin and may arise in association with germline or somatic mutations at or beyond codon 1444 of the APC gene.
S K, Clark, R K, Phillips
openaire +2 more sources
Chemoprevention in familial adenomatous polyposis [PDF]
Familial adenomatous polyposis (FAP) predictably leads to adenomas and eventual adenocarcinomas in the lower gastrointestinal tract and less frequently, the upper gastrointestinal tract. Chemopreventive strategies have been studied in FAP patients to delay the development of adenomas in the upper and lower gastrointestinal tract, as well as to prevent ...
Brian, Kim, Francis M, Giardiello
openaire +2 more sources
Familial polyposis coli: the management of desmoid tumor bleeding
There is currently no standard treatment for desmoid tumors (DTs) associated with familial polyposis coli (FAP). Familial adenomatous polyposis in DT patients is sometimes a life-threatening condition.
Calogero Armando +11 more
doaj +1 more source
Familial adenomatous polyposis in China
Familial adenomatous polyposis (FAP) is an autosomal dominant disease with a poor prognosis, and has been studied by clinicians and geneticists in China for the past three decades. It is estimated that FAP has an incidence of between 1 in 8,000 and 1 in 10,000 individuals, and accounts for 0.94% of colorectal cancer cases in China.
Jun, Yang +5 more
openaire +3 more sources
The Genomics of colorectal cancer: State of the art
The concept of the adenoma-carcinoma sequence, as first espoused by Morson et al. whereby the development of colorectal cancer is dependent on a stepwise progression from adenomatous polyp to carcinoma is well documented.
Hodgson, SV +3 more
core +1 more source
Genetic dissection of differential signaling threshold requirements for the Wnt/β-catenin pathway in vivo [PDF]
Contributions of null and hypomorphic alleles of Apc in mice produce both developmental and pathophysiological phenotypes. To ascribe the resulting genotype-to-phenotype relationship unambiguously to the Wnt/beta-catenin pathway, we challenged the allele
Newton, Ian P. +150 more
core +1 more source

